Your browser doesn't support javascript.
loading
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Praiss, Aaron M; Miller, Austin; Smith, Judith; Lichtman, Stuart M; Bookman, Michael; Aghajanian, Carol; Sabbatini, Paul; Backes, Floor; Cohn, David E; Argenta, Peter; Friedlander, Michael; Goodheart, Michael J; Mutch, David G; Gershenson, David M; Tewari, Krishnansu S; Wenham, Robert M; Wahner Hendrickson, Andrea E; Lee, Roger B; Gray, Heidi; Secord, Angeles Alvarez; Van Le, Linda; O'Cearbhaill, Roisin E.
Affiliation
  • Praiss AM; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: PraissA@mskcc.org.
  • Miller A; NRG Oncology Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY, United States of America. Electronic address: MillerA@NRGOncology.org.
  • Smith J; McGovern Medical School, The University of Texas Health Science Center, Houston, TX, United States of America. Electronic address: judith.ann.smith@uth.tmc.edu.
  • Lichtman SM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: LichtmaS@mskcc.org.
  • Bookman M; Department of Medical Oncology, Kaiser-Permanente Northern California, San Francisco, CA, United States of America. Electronic address: Michael.A.Bookman@kp.org.
  • Aghajanian C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: aghajanc@MSKCC.org.
  • Sabbatini P; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: sabbatip@mskcc.org.
  • Backes F; Department of Oncology, James Cancer Center, Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America. Electronic address: Floor.Backes@osumc.edu.
  • Cohn DE; Department of Oncology, James Cancer Center, Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America. Electronic address: David.Cohn@osumc.edu.
  • Argenta P; Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, United States of America. Electronic address: argenta@umn.edu.
  • Friedlander M; Department of Medical Oncology, Prince of Wales Hospital and Prince of Wales Clinical School, UNSW, Sydney, New South Wales, Australia. Electronic address: Michael.Friedlander@health.nsw.gov.au.
  • Goodheart MJ; Gynecologic Oncology, University of Iowa Hospitals, Iowa City, IA, United States of America. Electronic address: Michael-goodheart@uiowa.edu.
  • Mutch DG; Gynecologic Oncology, Washington University, St. Louis, MO, United States of America. Electronic address: mutchd@wustl.edu.
  • Gershenson DM; Gynecologic Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: dgershen@mdanderson.org.
  • Tewari KS; Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA, USA. Electronic address: ktewari@uci.edu.
  • Wenham RM; Gynecologic Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America. Electronic address: Robert.wenham@moffitt.org.
  • Wahner Hendrickson AE; Division of Medical Oncology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: WahnerHendrickson.Andrea@mayo.edu.
  • Lee RB; Gynecologic Oncology, Tacoma General Hospital, Tacoma, WA, United States of America.
  • Gray H; Gynecologic Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Electronic address: hgray@uw.edu.
  • Secord AA; Gynecologic Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of America. Electronic address: angeles.secord@duke.edu.
  • Van Le L; Gynecologic Oncology, University of North Carolina, United States of America. Electronic address: linda_van_le@med.unc.edu.
  • O'Cearbhaill RE; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address: ocearbhr@mskcc.org.
Gynecol Oncol ; 174: 213-223, 2023 07.
Article in En | MEDLINE | ID: mdl-37229879
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article